Rt-Pcr: Clinical Trials

5 trials of Rt-Pcr, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 12Completed 1, Terminated 1

Follow Rt-Pcr: new trials by email Literature Review of Rt-Pcr trials Research Report on Rt-Pcr

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Hsp90 inhibitor STA-9090, laboratory biomarker analysis, polymerase chain reaction - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer
Phase 2CompletedBarbara Ann Karmanos Cancer Institute182011-01-012018-09-18
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma
Phase 1 / Phase 2CompletedCase Comprehensive Cancer Center452010-06-012020-11-16
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
oxaliplatin, pemetrexed disodium, questionnaire administration - Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer
Phase 2CompletedUniversity of Southern California472006-06-012014-03-10
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma
Phase 1 / Phase 2TerminatedCity of Hope Medical Center292006-03-012015-04-01
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
celecoxib, recombinant interferon alfa-2b, polymerase chain reaction - Renal Cell Cancer, Stage IV Renal Cell Cancer
Phase 2CompletedCase Comprehensive Cancer Center172006-03-012012-08-07

Conditions studied

Prostatic Neoplasms (2)  ·  Carcinoma, Renal Cell (1)  ·  Liposarcoma (1)  ·  Multiple Myeloma (1)  ·  Sarcoma (1)

Sponsors

Case Comprehensive Cancer Center (2)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  City of Hope Medical Center (1)  ·  University of Southern California (1)

Countries

United States (5)

Top investigators

Brian Rini (1)  ·  Ehsan Malek, MD (1)  ·  Elisabeth Heath (1)  ·  Frederic Reu (1)  ·  Jacek Pinski (1)  ·  Warren Chow (1)

Results publications

PMID 24099865